{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:06Z","timestamp":1793289666666,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.breast.2024.103671","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T14:44:26Z","timestamp":1704465866000},"page":"103671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6789-9044","authenticated-orcid":false,"given":"Xuhui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechuang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.breast.2024.103671_bib1","first-page":"1668","article-title":"Surrogacy of pathologic complete response in trials of neoadjuvant therapy for early breast cancer: critical analysis of strengths, weaknesses, and misinterpretations","volume":"8","author":"Conforti","year":"2022","journal-title":"AMA Oncol"},{"key":"10.1016\/j.breast.2024.103671_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919827714","article-title":"Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives","volume":"11","author":"Caparica","year":"2019","journal-title":"Ther Adv Med Oncol"},{"issue":"12","key":"10.1016\/j.breast.2024.103671_bib3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/bjs\/znac305","article-title":"Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis","volume":"109","author":"Cocco","year":"2022","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.breast.2024.103671_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jso.26236","article-title":"Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments","volume":"123","author":"Esgueva","year":"2021","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.breast.2024.103671_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamasurg.2017.0562","article-title":"Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery","volume":"152","author":"Tadros","year":"2017","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.breast.2024.103671_bib6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamaoncol.2021.1371","article-title":"Three-Year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual ERBB2 blockade in patients with ERBB2-positive breast cancer: a secondary analysis of the TRAIN-2 randomized, phase 3 trial","volume":"7","author":"van der Voort","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10257","key":"10.1016\/j.breast.2024.103671_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2024.103671_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","article-title":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges","volume":"31","author":"Heil","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.breast.2024.103671_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.breast.2024.103671_bib10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"issue":"29","key":"10.1016\/j.breast.2024.103671_bib11","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103671_bib12","series-title":"Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis","author":"Che Bakri","year":"2022"},{"issue":"14","key":"10.1016\/j.breast.2024.103671_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2024.103671_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.breast.2021.09.013","article-title":"Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: a multicentre study on 1,950 patients","volume":"60","author":"Corsi","year":"2021","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.breast.2024.103671_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/tbj.13763","article-title":"Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy","volume":"26","author":"Fernandez-Gonzalez","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.breast.2024.103671_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231156146","article-title":"Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)","volume":"15","author":"Chen","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.breast.2024.103671_bib17","article-title":"The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: a multicenter real-world study (CSBrS-012)","volume":"11","author":"Li","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.breast.2024.103671_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-020-05970-2","article-title":"Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?","volume":"185","author":"Garcia-Tejedor","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.breast.2024.103671_bib31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamasurg.2018.2696","article-title":"Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy","volume":"153","author":"Barron","year":"2018","journal-title":"JAMA surg"},{"issue":"1","key":"10.1016\/j.breast.2024.103671_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.21037\/gs-20-573","article-title":"Predictive factors of pathologically node-negative disease for HER2 positive and triple-negative breast cancer after neoadjuvant therapy","volume":"10","author":"Shi","year":"2021","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.breast.2024.103671_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/SLA.0000000000004246","volume":"275","author":"Heil","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.breast.2024.103671_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2017170180","article-title":"Imaging neoadjuvant therapy response in breast cancer","volume":"285","author":"Fowler","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.breast.2024.103671_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2214\/AJR.16.17223","article-title":"Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer","volume":"208","author":"Rauch","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.breast.2024.103671_bib23","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1245\/s10434-020-09273-0","article-title":"Minimally invasive complete response assessment of the breast after neoadjuvant systemic therapy for early breast cancer (MICRA trial): interim analysis of a multicenter observational cohort study","volume":"28","author":"van Loevezijn","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.breast.2024.103671_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.4103","article-title":"Accuracy of post-neoadjuvant chemotherapy image-guided breast biopsy to predict residual cancer","volume":"155","author":"Tasoulis","year":"2020","journal-title":"JAMA Surg"},{"issue":"17","key":"10.1016\/j.breast.2024.103671_bib25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1200\/JCO.21.02439","article-title":"Intelligent vacuum-assisted biopsy to identify breast cancer patients with pathologic complete response (ypT0 and ypN0) after neoadjuvant systemic treatment for omission of breast and axillary surgery","volume":"40","author":"Pfob","year":"2022","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.breast.2024.103671_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.breast.2024.103671_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2024.103671_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.breast.2024.103671_bib29","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1245\/s10434-014-3775-6","article-title":"Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?","volume":"21","author":"Mittendorf","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2024.103671_bib30","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2020","journal-title":"Ann Surg"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762400002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762400002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:47:56Z","timestamp":1760777276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762400002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"alternative-id":["S096097762400002X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103671","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103671"}}